Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Very low
Treating people living with HIV for mild to moderate histoplasmosis: itraconazole 200 mg three times daily for three days and then 200 mg twice daily is recommended
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
Year2020
InstitutionPan American Health Organization
Guideline
WHO guidelines on the management of advanced HIV disease
Year2025
InstitutionWorld Health Organization